HMI-202: Investigational Gene Therapy for Treatment of Metachromatic Leukodystrophy

HMI-202: Investigational Gene Therapy for Treatment of Metachromatic Leukodystrophy

Gingras J, St-Martin T, Gall K, et al. WORLDSymposium 2020.